drugset / Trial / NCT00424424

A Study to Evaluate the Efficacy of MK0719 in the Prevention of Postoperative Dental Pain (0719-002)

NCT00424424 ↗

Phase 2 Terminated 81 enrolled Merck Sharp & Dohme LLC
RandomizedSingle-groupDouble-blindPrevention

Summary

This study is being conducted to evaluate the safety and tolerability of the drug and to evaluate its efficacy compared to placebo and to ibuprofen in the prevention of postoperative dental pain in male patients. This is an early phase trial and some specific protocol information is proprietary and not publicly available at this time. (Full information is available to trial participants).

Timeline

Start
2006-08
Primary completion
2007-01
Completion
2007-01

Drugs

EvaluationDrugModalityDoseRoute
Subject MK0719 Unknown — —

Indications

No indication recorded.